| 000 | 01892 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250516234656.0 | ||
| 264 | 0 | _c20150626 | |
| 008 | 201506s 0 0 eng d | ||
| 022 | _a1520-6017 | ||
| 024 | 7 |
_a10.1002/jps.24190 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTaraballi, Francesca | |
| 245 | 0 | 0 |
_aPotential avoidance of adverse analgesic effects using a biologically "smart" hydrogel capable of controlled bupivacaine release. _h[electronic resource] |
| 260 |
_bJournal of pharmaceutical sciences _cNov 2014 |
||
| 300 |
_a3724-3732 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnesthetics, Local _xadministration & dosage |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBupivacaine _xadministration & dosage |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aChemistry, Pharmaceutical |
| 650 | 0 | 4 |
_aChitosan _xchemistry |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 | _aDrug Carriers |
| 650 | 0 | 4 | _aHydrogels |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 |
_aInflammation Mediators _xmetabolism |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aLactic Acid _xchemistry |
| 650 | 0 | 4 |
_aMacrophages _ximmunology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aParticle Size |
| 650 | 0 | 4 | _aPhagocytosis |
| 650 | 0 | 4 |
_aPoloxamer _xchemistry |
| 650 | 0 | 4 |
_aPolyglycolic Acid _xchemistry |
| 650 | 0 | 4 | _aPolylactic Acid-Polyglycolic Acid Copolymer |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 |
_aTechnology, Pharmaceutical _xmethods |
| 700 | 1 | _aMinardi, Silvia | |
| 700 | 1 | _aCorradetti, Bruna | |
| 700 | 1 | _aYazdi, Iman K | |
| 700 | 1 | _aBalliano, Marta A | |
| 700 | 1 | _aVan Eps, Jeffrey L | |
| 700 | 1 | _aAllegri, Massimo | |
| 700 | 1 | _aTasciotti, Ennio | |
| 773 | 0 |
_tJournal of pharmaceutical sciences _gvol. 103 _gno. 11 _gp. 3724-3732 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jps.24190 _zAvailable from publisher's website |
| 999 |
_c24232490 _d24232490 |
||